Literature DB >> 17140890

Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer.

Shiro Oka1, Shinji Tanaka, Iwao Kaneko, Ritsuo Mouri, Mayuko Hirata, Toru Kawamura, Masaharu Yoshihara, Kazuaki Chayama.   

Abstract

BACKGROUND: In EMR of early gastric cancer (EGC), en bloc resection reduces the risk of residual cancer. Endoscopic submucosal dissection (ESD) now allows en bloc resection of large EGCs.
OBJECTIVE: To retrospectively determine whether ESD is more advantageous than EMR for EGCs.
DESIGN: EMR (825 lesions, 711 patients) or ESD (195 lesions, 185 patients) was performed. The en bloc resection rate, histologically complete resection rate, operation time, complications, and local recurrence rate were studied in relation to ulceration.
SETTING: Hiroshima University Hospital. PATIENTS: Subjects comprised 896 patients in whom 1020 EGCs were resected endoscopically from 1990 to 2004.
RESULTS: In cases without ulceration, en bloc and histologically complete resection rates were significantly higher with ESD than with EMR, regardless of tumor size. The frequency of ulceration did not differ significantly between groups. Average operation time was significantly longer for ESD than for EMR, regardless of tumor size. Also, regardless of ulceration, the incidence of intraoperative bleeding was significantly higher with ESD (22.6%) than with EMR (7.6%). Delayed bleeding did not differ. In cases with ulceration, the incidence of perforation was significantly higher with ESD (53.8%) than with EMR (2.9%). Local recurrences were treated by incomplete EMR (en bloc, 2.9%; piecemeal, 4.4%). No patient experienced recurrence after ESD.
CONCLUSIONS: ESD increased en bloc and histologically complete resection rates and may reduce the local recurrence rate. Increased operation time and complication risks with ESD in comparison with EMR remain problematic. Special measures are necessary for ESD of ulcerated lesions to reduce the rates of perforation and incomplete resection.

Entities:  

Mesh:

Year:  2006        PMID: 17140890     DOI: 10.1016/j.gie.2006.03.932

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  268 in total

1.  Management of bleeding and artificial gastric ulcers associated with endoscopic submucosal dissection.

Authors:  Yosuke Muraki; Shotaro Enomoto; Mikitaka Iguchi; Mitsuhiro Fujishiro; Naohisa Yahagi; Masao Ichinose
Journal:  World J Gastrointest Endosc       Date:  2012-01-16

Review 2.  Management of the complications of endoscopic submucosal dissection.

Authors:  Seong Hwan Kim; Jeong Seop Moon; Young Hoon Youn; Ki Myung Lee; Sung Joon Lee
Journal:  World J Gastroenterol       Date:  2011-08-21       Impact factor: 5.742

3.  Technical issues and new devices of ESD of early gastric cancer.

Authors:  Wan Sik Lee; Jin Woong Cho; Young Dae Kim; Kyu Jong Kim; Byung Ik Jang
Journal:  World J Gastroenterol       Date:  2011-08-21       Impact factor: 5.742

Review 4.  Endoscopic submucosal dissection--current success and future directions.

Authors:  Hironori Yamamoto
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-06-05       Impact factor: 46.802

5.  Predictive factors for local recurrence after endoscopic resection for early gastric cancer: long-term clinical outcome in a single-center experience.

Authors:  Jun Chul Park; Sang Kil Lee; Ju Hee Seo; Yu Jin Kim; Hyunsoo Chung; Sung Kwan Shin; Yong Chan Lee
Journal:  Surg Endosc       Date:  2010-04-29       Impact factor: 4.584

6.  Efficacy and safety of endoscopic submucosal dissection for early gastric cancer in patients with comorbid diseases.

Authors:  Beom Jin Kim; Tae Hoon Chang; Jae J Kim; Byung-Hoon Min; Jun Haeng Lee; Hee Jung Son; Poong-Lyul Rhee; Jong Chul Rhee; Kyung Mee Kim; Chul Keun Park
Journal:  Gut Liver       Date:  2010-06-16       Impact factor: 4.519

7.  A Western single-center experience with endoscopic submucosal dissection for early gastrointestinal cancers.

Authors:  Sergio Coda; Paolo Trentino; Fabio Antonellis; Barbara Porowska; Francesco Gossetti; Franco Ruberto; Francesco Pugliese; Giulia D'Amati; Paolo Negro; Takuji Gotoda
Journal:  Gastric Cancer       Date:  2010-12-03       Impact factor: 7.370

8.  Endoscopic treatments of gastric mucosal lesions are not riskier in patients with chronic renal failure or liver cirrhosis.

Authors:  Young Lan Kwon; Eun Soo Kim; Kyung In Lee; Yong Jin Kim; Chang Wook Park; Yun Jung Kim; Hye Jin Seo; Kwang Bum Cho; Kyung Sik Park; Byoung Kuk Jang; Woo Jin Chung; Jae Seok Hwang
Journal:  Surg Endosc       Date:  2010-12-07       Impact factor: 4.584

Review 9.  Treatment modalities for early gastric cancer.

Authors:  Jesús Espinel; Eugenia Pinedo; Vanesa Ojeda; Maria Guerra Del Rio
Journal:  World J Gastrointest Endosc       Date:  2015-09-10

10.  Predictive factors of endoscopic submucosal dissection procedure time for gastric superficial neoplasia.

Authors:  Zhong-Sheng Lu; Yun-Sheng Yang; Dan Feng; Shu-Fang Wang; Jing Yuan; Jin Huang; Xiang-Dong Wang; Jiang-Yun Meng; Hong Du; Hong-Bin Wang
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.